Thank you for your interest in VARIZIG®.
If you need further assistance or have questions, please share your contact information and a Kamada representative will contact you promptly.
To report SUSPECTED ADVERSE REACTIONS, contact Kamada at pharmacovigilance@kamada.com or 1-(866)-916-0077 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
Kamada Inc. 221 River St., 9th floor, Hoboken, NJ 07030
VARIZIG® contains trace amounts of IgA. Individuals known to have anaphylactic or severe systemic (hypersensitivity)
VARIZIG® contains trace amounts of IgA. Individuals known to have anaphylactic or severe systemic (hypersensitivity) reactions to human immune globulin preparations should not receive VARIZIG®. IgA-deficient patients with antibodies against IgA and a history of hypersensitivity may have an anaphylactoid reaction. Thrombotic events may occur during or following treatment with immune globulin products.